Award Year / Program / Phase:1997 / SBIR / Phase I
Agency:HHS
Principal Investigator:Ross, mark m
Award Amount:$100,000.00
Abstract:
In the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach… More